The patents at
issue in the case are owned by Cornell University and are licensed to OptiGen for canine genetic testing related to progressive retinal atrophy (PRA - prcd), Collie eye anomaly (CEA), congenital stationary
night blindness (CSNB), and Retinal dysplasia / Oculoskeletal dysplasia (RD / OSD).
Prone to hives caused by stress or insect bites, cerebellar ataxia - an undefined problem in the part of the brain that controls coordination, PRA (Progressive retinal atrophy)- gradual deterioration of the retina beginning with
night blindness and eventually total
blindness, allergies, cancer, heart problems, socialization
issues, training and hip dysplasia, thyroid problems